BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Haiart S, Watson DI, Leong MP, Astill D, Bright T, Hussey DJ. MicroRNA-196a & microRNA-101 expression in Barrett's oesophagus in patients with medically and surgically treated gastro-oesophageal reflux. BMC Res Notes 2011;4:41. [PMID: 21352563 DOI: 10.1186/1756-0500-4-41] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Saadatian Z, Nariman-Saleh-Fam Z, Khaheshi I, Mansoori Y, Daraei A, Ghaderian SMH, Omrani MD. Peripheral Blood Mononuclear Cells Expression Levels of miR-196a and miR-100 in Coronary Artery Disease Patients. Immunol Invest 2020;:1-11. [PMID: 32928012 DOI: 10.1080/08820139.2020.1791177] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Syllaios A, Sakellariou S, Garmpis N, Sarlani E, Damaskos C, Apostolou K, Kykalos S, Gazouli M, Karavokyros I, Schizas D. The role of miR-101 in esophageal and gastric cancer. Per Med 2021;18:491-9. [PMID: 34402321 DOI: 10.2217/pme-2021-0024] [Reference Citation Analysis]
3 Lu YC, Chang JT, Liao CT, Kang CJ, Huang SF, Chen IH, Huang CC, Huang YC, Chen WH, Tsai CY, Wang HM, Yen TC, You GR, Chiang CH, Cheng AJ. OncomiR-196 promotes an invasive phenotype in oral cancer through the NME4-JNK-TIMP1-MMP signaling pathway. Mol Cancer 2014;13:218. [PMID: 25233933 DOI: 10.1186/1476-4598-13-218] [Cited by in Crossref: 56] [Cited by in F6Publishing: 62] [Article Influence: 7.0] [Reference Citation Analysis]
4 Kresty LA, Clarke J, Ezell K, Exum A, Howell AB, Guettouche T. MicroRNA alterations in Barrett's esophagus, esophageal adenocarcinoma, and esophageal adenocarcinoma cell lines following cranberry extract treatment: Insights for chemoprevention. J Carcinog 2011;10:34. [PMID: 22279419 DOI: 10.4103/1477-3163.91110] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
5 Gui T, Shen K. miRNA-101: A potential target for tumor therapy. Cancer Epidemiology 2012;36:537-40. [DOI: 10.1016/j.canep.2012.05.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
6 Wang N, Li Y, Zhou RM, Wang GY, Wang CM, Chen ZF, Liu W. Hsa-miR-196a2 functional SNP is associated with the risk of ESCC in individuals under 60 years old. Biomarkers 2014;19:43-8. [PMID: 24320161 DOI: 10.3109/1354750X.2013.866164] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]